Published Paper Details:

Abnormal uterine bleeding is characterized by severe menstrual loss which affects women's quality of life in terms of physical, emotional, sexual, and professional elements in their lives. Women may need immediate treatment fluid replacement and prescription of hemostatic drugs in acute and severe cases of bleeding Surgery may be necessary in certain special cases when it is more difficult and prolonged bleeding. Current International Classification System of Gynecology and Obstetrics (FIGO) and PALM-COEIN were the didactic basis of various treatment options. The following conditions are causes of abnormal uterine bleeding - PALM-COEIN: uterine polyps (P), adenomyosis (A), leiomyomas (L), uterine body precursors and malignant lesions (M), coagulopathies (C), ovulation dysfunction (O), endometrial dysfunction (E), iatrogenic (I) and not yet classified (N). The main goals of treatment are to reduce the menstrual cycle, reduce morbidity and improve quality of life. It is important to emphasize that although the goal of treatment in the acute phase is to stabilize the patient hemodynamically and stop severe bleeding, which is the focus of treatment in the chronic phase, the etiology and clinical symptoms of menstrual dysfunction are discussed. Surgery is an option and treatment mostly focuses on hormone treatment, anti-inflammatory drugs, and antifibrinolytic drugs. In this review article, we discuss about the epidemiology, etiology, pathophysiology, risk factors involved, diagnosis, and various treatment options available for abnormal uterine bleeding in women with acute and chronic bleeding.